Topical recombinant human vascular endothelial growth factor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Topical recombinant human vascular endothelial growth factor, covering 2013-01-25 to 2013-01-25. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Effect of Topical Recombinant Human Vascular Endothelial Growth Factor for Induction of Healing of Diabetic Foot Ulcers [Phase 2]